Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allogeneic natural killer cells SAR445419

A preparation of allogeneic, off-the-shelf (OTS) ex vivo-expanded natural killer (NK) cells, with potential cytolytic and antineoplastic activities. Upon infusion of the allogeneic NKs SAR445419, these cells may lyse cancer cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	NK cells KDS-1001 NKs KDS-1001
Code name:	KDS 1001 KDS-1001 KDS1001 SAR 445419 SAR-445419 SAR445419

allogeneic natural killer cells SAR445419

Search NCI's Drug Dictionary